Option Care Health Inc
For the period ended Jun 30, 2024. Filed Jul 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 31, 2024
OPCH$31.65-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Stockholders’ Equity
(IN THOUSANDS)
| Preferred Stock | Common Stock | Treasury Stock | Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | |
|---|---|---|---|---|---|---|---|
| Balance - December 31, 2022 | $— | $18 | $(2,403) | $1,176,906 | $190,423 | $21,159 | $1,386,103 |
| Exercise of stock options, vesting of restricted stock, and related tax withholdings | — | — | — | (1,902) | — | — | (1,902) |
| Stock-based incentive compensation | — | — | — | 5,988 | — | — | 5,988 |
| Purchase of company stock | — | — | (75,735) | — | — | — | (75,735) |
| Net income | — | — | — | — | 39,208 | — | 39,208 |
| Other comprehensive loss | — | — | — | — | — | (3,443) | (3,443) |
| Balance - March 31, 2023 | $— | $18 | $(78,138) | $1,180,992 | $229,631 | $17,716 | $1,350,219 |
| Exercise of stock options, vesting of restricted stock, and related tax withholdings | — | — | — | (247) | — | — | (247) |
| Stock-based incentive compensation | — | — | — | 7,685 | — | — | 7,685 |
| Purchase of company stock, and related tax effects | — | — | 32 | — | — | — | 32 |
| Net income | — | — | — | — | 114,403 | — | 114,403 |
| Other comprehensive income | — | — | — | — | — | 3,291 | 3,291 |
| Balance - June 30, 2023 | $— | $18 | $(78,106) | $1,188,430 | $344,034 | $21,007 | $1,475,383 |
| Balance - December 31, 2023 | $— | $18 | $(255,107) | $1,204,270 | $457,513 | $14,978 | $1,421,672 |
| Exercise of stock options, vesting of restricted stock, and related tax withholdings | — | — | — | (8,182) | — | — | (8,182) |
| Stock-based incentive compensation | — | — | — | 9,605 | — | — | 9,605 |
| Purchase of company stock, and related tax effects | — | — | (40,289) | — | — | — | (40,289) |
| Net income | — | — | — | — | 44,791 | — | 44,791 |
| Other comprehensive income | — | — | — | — | — | 1,551 | 1,551 |
| Balance - March 31, 2024 | $— | $18 | $(295,396) | $1,205,693 | $502,304 | $16,529 | $1,429,148 |
| Exercise of stock options, vesting of restricted stock, and related tax withholdings | — | — | — | 1,299 | — | — | 1,299 |
| Stock-based incentive compensation | — | — | — | 7,608 | — | — | 7,608 |
| Purchase of company stock, and related tax effects | — | — | (78,768) | — | — | — | (78,768) |
| Net income | — | — | — | — | 53,043 | — | 53,043 |
| Other comprehensive loss | — | — | — | — | — | (899) | (899) |
| Balance - June 30, 2024 | $— | $18 | $(374,164) | $1,214,600 | $555,347 | $15,630 | $1,411,431 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.